· Form D filing · Baseline
Reported sold as filed: $4,972,500 · Offering amount as filed: $10,000,000
SEC source checked 29 Oct 2026. This is the issuer’s historical filing, not a current valuation.
View original evidence ↗Solaris Endovascular Inc.
On its website, the company describes its work as “With a proven stent platform and innovative drug-eluting technology, we are revolutionizing endovascular solutions for dialysis access and peripheral artery disease (PAD). Get in touch…”.
- Industry
- Biotechnology
- Tracked VC backers
- 0
- Location
- Not recorded
Publicly documented VC backing
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
No tracked VC backing is recorded.